Smoking cessation in severe mental illness: combined long-term quit rates from the UK SCIMITAR trials programme.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 31685048.
- Also identified by DOI 10.1192/bjp.2019.192.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Smoking contributes to health inequalities for people with severe mental illness (SMI). Although smoking cessation interventions are effective in the short term, there are few long-term trial-based estimates of abstinence. The SCIMITAR trials programme includes the largest trial to date of a smoking cessation intervention for people with SMI, but this was underpowered to detect anticipated long-term quit rates. By pooling pilot and full-trial data we found that quit rates were maintained at 12 months (OR = 1.67, 95% CI 1.02-2.73, P = 0.04). Policymakers can now be confident that bespoke smoking cessation interventions produce successful short- and long-term quitting.
Medical subject headings
- Mental Disorders
- Smoking Cessation